Remifentanil

DB00899ApprovedInvestigationalSmall moleculeOpiate AgonistsOpioid Agonist

Remifentanil is an opioid analgesic used in anesthesia. Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic.

Chemical structure of Remifentanil
Mechanism
Curator reviewed
Primary indication
For use during the induction and maintenance of general anesthesia.Curator reviewed · 3 structured indications
Formula / weight
C20H28N2O5 · 376.4467 g/mol (avg)
First approval
Canada, 2011 · United States, 1996
Also known as
Remi-fentanyl · Remifentanyl
Code names
GI 87084X · IDS-NR-005
Brand names
  • Ultiva

Resolves to

Compound
UNIIP10582JYYKCAS132875-61-7ChEMBLCHEMBL1005ChEBI8802PubChem60815KEGGD08473
Clinical / RWD
RxNorm73032ATCN01AH06PharmGKBPA451232
Structure
InChIKeyZTVQQQVZCWLTDF-UHFFFAOYSA-NSMILESCCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC
Targets
P35372OPRM1P41143OPRD1P41145OPRK1

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,715Drug interactionsStructured to mechanism, not free text
Sign in
631Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
140Marketed productsAcross 9 countries and 39 labellers
Sign in
1ATC codeIncluding every combination product, plus 29 drug categories
Sign in
18+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Remifentanil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In